Actos, Avandia Safety Studies Should Assess New Glitazone Patients - Cmte.
Executive Summary
Actos and Avandia studies should evaluate safety in patients who were not previously treated with Warner-Lambert's Rezulin, members of FDA's Endocrinologic & Metabolic Drugs Advisory Committee said May 19.